Guys, the two major, obvious catalysts have been c
Post# of 36566
(Total Views: 116)
Posted On: 01/28/2019 6:41:13 AM
Guys, the two major, obvious catalysts have been completed, for the most part. The GNBT dividend shares have been distributed and the date to qualify for the NI-O dividend shares has passed. We still don't know the value of NI-O shares.
The daytraders will sell, like Friday, and buy when the next big PR is issued. More acquisitions won't necessarily move the needle. What will move the needle is progress with AE37 and to a lesser degree O-L. Perhaps sales of Excellagen. Positive new on AE37 before 2/25 should heat things up.
The other news that will move the needle is earnings, unexpected sources of income, perhaps additional spin-offs, and most importantly, uplisting. Without any of these there will be backing and filling to the fair market price. The TA guys can help us figure that out.
The foam has been sipped of the latte', and it was delicious. However, the coffee has to hold up its end of the bargain. We have no reason to believe that it won't. I just don't think we can expect 300% growth every two months. That level of growth makes no sense for any legitimate company.
The daytraders will sell, like Friday, and buy when the next big PR is issued. More acquisitions won't necessarily move the needle. What will move the needle is progress with AE37 and to a lesser degree O-L. Perhaps sales of Excellagen. Positive new on AE37 before 2/25 should heat things up.
The other news that will move the needle is earnings, unexpected sources of income, perhaps additional spin-offs, and most importantly, uplisting. Without any of these there will be backing and filling to the fair market price. The TA guys can help us figure that out.
The foam has been sipped of the latte', and it was delicious. However, the coffee has to hold up its end of the bargain. We have no reason to believe that it won't. I just don't think we can expect 300% growth every two months. That level of growth makes no sense for any legitimate company.
(1)
(0)